News tagged with bovine spongiform encephalopathy
Researchers find new piece of BSE puzzle
Nov 20, 2009 |
not rated yet |
0
A new treatment route for bovine spongiform encephalopathy (BSE) and its human form Creutzfeldt Jakob disease (CJD) could be a step closer based on new results from scientists at the University of Leeds. The team has found ...
Protecting humans and animals from diseases in wildlife
Oct 07, 2009 |
not rated yet |
0
Avian influenza (H5N1), rabies, plague, Bovine Spongiform Encephalopathy (BSE), and more recently swine flu (H1N1) are all examples of diseases that have made the leap from animals to humans. As the list continues to grow, ...
Scientists uncover evolutionary origins of prion disease gene
Sep 28, 2009 |
4 / 5 (1) |
0
A University of Toronto-led team has uncovered the evolutionary ancestry of the prion gene, which may reveal new understandings of how the prion protein causes diseases such as bovine spongiform encephalopathy (BSE), also ...
Impaired transport in neurons triggers prion disease
Aug 21, 2009 |
not rated yet |
0
A new study shows that nervous system integrity and axonal properties may play a key role in prion diseases. The findings, from researchers at the Rudolf Virchow Center and the Institute of Virology of the University of Würzburg, ...
Species barrier may protect macaques from chronic wasting disease
Jul 30, 2009 |
5 / 5 (1) |
0
Data from an ongoing multi-year study suggest that people who consume deer and elk with chronic wasting disease (CWD) may be protected from infection by an inability of the CWD infectious agent to spread to people. The results ...
Prevalence of variant CJD agent in Britain remains uncertain
May 21, 2009 |
not rated yet |
0
First results from a large tissue survey in Britain of the agent that causes variant Creutzfeldt-Jakob disease (vCJD) are unable so far to establish that the prevalence is lower than that given by previous estimates, concludes ...
Antibody key to treating variant CJD, scientists find
Mar 04, 2009 |
5 / 5 (3) |
0
Scientists at the University of Liverpool have determined the atomic structure of the 'binding' between a brain protein and an antibody that could be key to treating patients with diseases such as variant CJD.
